The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-α production
Authors:
- Christian C HaudenschildCHChristian C Haudenschild
- Achsah D KeeganAKAchsah D Keegan
- Yufang ShiYSYufang Shi
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 18 (5) , 476-484
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Hepatic Microvascular Responses to SepsisSeminars in Thrombosis and Hemostasis, 2000
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994
- Tumor necrosis factor-α as a myocardial depressant substanceInternational Journal of Cardiology, 1993
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shockLife Sciences, 1992
- T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.Journal of Experimental Medicine, 1992
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.Journal of Experimental Medicine, 1989
- Opioid receptors on cells of the immune system: evidence for δ- and κ-classesJournal of Endocrinology, 1989
- Endotoxins of gram-negative bacteriaPharmacology & Therapeutics, 1981